...
首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >Stability-indicating spectrophotometric methods for determination of the anticoagulant drug apixaban in the presence of its hydrolytic degradation product
【24h】

Stability-indicating spectrophotometric methods for determination of the anticoagulant drug apixaban in the presence of its hydrolytic degradation product

机译:稳定性指示分光光度法在水解降解产物存在下测定抗凝药物阿哌沙班的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Apixaban (a novel anticoagulant agent) was subjected to a stress stability study including acid, alkali, oxidative, photolytic, and thermal degradation. The drug was found to be only liable to acidic and alkaline hydrolysis. The degradation product was then isolated and identified by IR and GC-mass spectrometry. Four spectrophotometric methods, namely; first derivative (D-1), derivative ratio (DR), ratio difference (RD) and mean centering of ratio spectra (MCR), have been suggested for the determination of apixaban in presence of its hydrolytic degradation product. The proposed methods do not require any preliminary separation step. The accuracy, precision and linearity ranges of the proposed methods were determined, and the methods were validated as per ICH guidelines and the specificity was assessed by analyzing synthetic mixtures containing different percentages of the degradation product with the drug. The developed methods were successfully applied for the determination of apixaban in bulk powder and its tablet dosage form. (C) 2016 Elsevier B.V. All rights reserved.
机译:阿哌沙班(一种新型抗凝剂)进行了应力稳定性研究,包括酸,碱,氧化,光解和热降解。发现该药物仅易于酸性和碱性水解。然后分离降解产物并通过IR和GC-质谱法鉴定。四种分光光度法,即已经建议使用一阶导数(D-1),导数比(DR),比率差(RD)和比率谱的平均居中(MCR)来确定apixaban存在水解降解产物的情况。所提出的方法不需要任何初步的分离步骤。确定了所提出方法的准确性,精密度和线性范围,并根据ICH指南对方法进行了验证,并通过分析包含不同百分比降解产物的合成混合物与药物来评估特异性。所开发的方法已成功地用于散装粉末及其片剂剂型中阿哌沙班的测定。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号